FDA approves nasal spray for emergency allergic reactions
The Checkup by Singlecare
AUGUST 12, 2024
Food and Drug Administration (FDA) approved neffy, a nasal spray for the emergency treatment of anaphylaxis. The approval comes more than three decades after epinephrine was first approved by the FDA for the treatment of anaphylaxis in 1987. On August 9, the U.S. When will neffy be available? within the next eight weeks.
Let's personalize your content